Co-Formulate has the formulation, analytical and regulatory expertise to support your product development requirements. We principally operate in the Pharmaceutical, Healthcare, Personal Care, Vitamins, Minerals and Supplements (VMS) and Veterinary sectors and have an unblemished record of working successfully with global blue-chip organisations, SMEs, research-based organisations and academic groups. We have state of the art laboratory and processing facilities, located at MediCity (Nottingham, UK) enabling us to undertake formulation development, analytical and stability studies across all major dosage formats. In 2015, Co-Formulate was acquired by drug development specialist Quotient Clinical. The partnership will enable Co-Formulate to expand their capabilities and subsequently deliver seamless programs consisting of formulation development, clinical trial manufacturing and clinical testing, all under the umbrella of a single organisation.
View Top Employees from Co-Formulate LimitedWebsite | http://www.co-formulate.co.uk |
Revenue | $6 million |
Employees | 5 (2 on RocketReach) |
Founded | 2007 |
Phone | +44 115 706 0418 |
Technologies |
JavaScript,
HTML,
Twitter
+23 more
(view full list)
|
Industry | Pharmaceuticals, Drug Manufacturing & Research, Healthcare |
SIC | SIC Code 2834 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Co-Formulate Limited employee's phone or email?
The Co-Formulate Limited annual revenue was $6 million in 2023.
2 people are employed at Co-Formulate Limited.
Co-Formulate Limited is based in Nottingham, Nottingham.
The NAICS codes for Co-Formulate Limited are [3254, 32541, 325, 32].
The SIC codes for Co-Formulate Limited are [2834, 283, 28].